CN1860224A - 使间充质干细胞分化成神经细胞的方法以及含有该神经细胞的用于神经退行性疾病的药物组合物 - Google Patents
使间充质干细胞分化成神经细胞的方法以及含有该神经细胞的用于神经退行性疾病的药物组合物 Download PDFInfo
- Publication number
- CN1860224A CN1860224A CNA2003801106268A CN200380110626A CN1860224A CN 1860224 A CN1860224 A CN 1860224A CN A2003801106268 A CNA2003801106268 A CN A2003801106268A CN 200380110626 A CN200380110626 A CN 200380110626A CN 1860224 A CN1860224 A CN 1860224A
- Authority
- CN
- China
- Prior art keywords
- cell
- stem cell
- neurocyte
- mescenchymal stem
- substratum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/12—Hepatocyte growth factor [HGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
- C12N2506/1353—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from bone marrow mesenchymal stem cells (BM-MSC)
Abstract
Description
预处理 | 时间(周) | 接种的细胞数 | 只含有肝细胞生长因子 | 只含有表皮生长因子 | 表皮生长因子和干细胞生长因子 |
未铺满培养 | 4 | 7.5×107 | 没有增殖 | 1×105 | 2.0×105 |
铺满培养 | 2 | 7.5×107 | 没有增殖 | 1.2×105 | 1.8×105 |
预处理 | 时间(周) | 只含有肝细胞生长因子 | 只含有表皮生长因子 | 表皮生长因子和干细胞生长因子 |
未铺满培养 | 4 | 没有增殖 | 2×105 | 2×105 |
8 | 没有增殖 | 5×105 | 1×105 | |
铺满培养 | 4 | 没有增殖 | 2×105 | 1.7×105 |
8 | 没有增殖 | 5×105 | 1.3×105 |
时间(周) | NSE | NeuN | GFAP | MAP-2 | 阴性细胞 | |
只含有表皮生长因子 | 4 | 0.9% | 0.8% | 1.2% | . | 89% |
表皮生长因子和干细胞生长因子 | 2 | 10% | 25% | 4% | . | 70% |
表皮生长因子和干细胞生长因子 | 4 | 56% | 75% | 24% | . | 20% |
约24小时铺满培养后,表皮生长因子和干细胞生长因子 | 2 | 62% | 88% | 31% | 11% | 10% |
Claims (8)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/KR2003/002302 WO2005040362A1 (en) | 2003-10-29 | 2003-10-29 | Method for differentiating mesenchymal stem cell into neural cell and pharmaceutical composition containing the neural cell for neurodegenerative disease |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1860224A true CN1860224A (zh) | 2006-11-08 |
CN100554409C CN100554409C (zh) | 2009-10-28 |
Family
ID=34510740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2003801106268A Expired - Fee Related CN100554409C (zh) | 2003-10-29 | 2003-10-29 | 使间充质干细胞分化成神经细胞的方法 |
Country Status (10)
Country | Link |
---|---|
US (1) | US7635591B2 (zh) |
EP (1) | EP1687413B8 (zh) |
JP (1) | JP4126060B2 (zh) |
CN (1) | CN100554409C (zh) |
AT (1) | ATE388223T1 (zh) |
AU (1) | AU2003273118B2 (zh) |
CA (1) | CA2543118C (zh) |
DE (1) | DE60319599T8 (zh) |
HK (1) | HK1093755A1 (zh) |
WO (1) | WO2005040362A1 (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012034296A1 (zh) * | 2010-09-13 | 2012-03-22 | 中山大学中山眼科中心 | 人表皮源性间充质干细胞样多能细胞及其制备方法 |
CN103275070A (zh) * | 2013-05-10 | 2013-09-04 | 郑彪 | 调节单核细胞增殖的四环化合物及其应用 |
CN103919806A (zh) * | 2014-04-09 | 2014-07-16 | 大连医科大学 | 骨髓间充质干细胞作为治疗正己烷致周围性神经病的药物的应用 |
CN112646774A (zh) * | 2014-09-11 | 2021-04-13 | 台湾粒线体应用技术股份有限公司 | 用线粒体特化细胞治疗神经退行性疾病的医药组合物 |
CN112646774B (zh) * | 2014-09-11 | 2024-05-17 | 台湾粒线体应用技术股份有限公司 | 用线粒体特化细胞治疗神经退行性疾病的医药组合物 |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004069172A2 (en) | 2003-01-30 | 2004-08-19 | The Government of the United States of America as represented by the Department of Veterans Affairs | Multilineage-inducible cells and uses thereof |
JP2006524092A (ja) * | 2003-04-24 | 2006-10-26 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 非侵襲性左心室容積決定 |
US20090136461A1 (en) * | 2007-11-28 | 2009-05-28 | Moon Suk Kim | Neuronal differentiation method of adult stem cells using small molecules |
US20120156134A1 (en) | 2007-12-20 | 2012-06-21 | Shayne Squires | Compositions and methods for detecting or eliminating senescent cells to diagnose or treat disease |
NZ591292A (en) | 2008-08-20 | 2012-10-26 | Anthrogenesis Corp | Improved cell composition and methods of making the same |
US8790638B2 (en) * | 2009-02-04 | 2014-07-29 | Stemedica Cell Technologies, Inc. | Compositions of stem cells and stem cell factors and methods for their use and manufacture |
CN102439136A (zh) | 2009-03-26 | 2012-05-02 | 加州大学校董 | 产生用于疾病修饰的抑制性rna的间充质干细胞 |
WO2012156968A2 (en) * | 2011-05-19 | 2012-11-22 | Ariel - University Research And Development Company, Ltd. | Use of mesenchymal stem cells for the improvement of affective and cognitive function |
KR101446711B1 (ko) * | 2011-05-23 | 2014-10-06 | 아주대학교산학협력단 | 간세포 성장인자 유전자 및 염기성 나선-고리-나선 계열의 신경형성 전사인자 유전자가 도입된 성체 줄기세포주 및 그의 용도 |
US20140065110A1 (en) | 2012-08-31 | 2014-03-06 | The Regents Of The University Of California | Genetically modified msc and therapeutic methods |
CN104004713A (zh) * | 2014-05-14 | 2014-08-27 | 安沂华 | 脐带间充质干细胞诱导培养为神经细胞的方法 |
WO2022046771A1 (en) * | 2020-08-24 | 2022-03-03 | The Johns Hopkins University | Juvenile protective factors to arrest and reverse aging in the enteric nervous system |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6214334B1 (en) * | 1991-10-21 | 2001-04-10 | Trustees Of The University Of Pennsylvania | Compositions and methods for producing and using homogenous neuronal cell transplants to treat neurodegenerative disorders and brain and spinal cord injuries |
AU716811B2 (en) * | 1994-11-14 | 2000-03-09 | Neurospheres Holdings Ltd | Regulation of neural stem cell proliferation |
US5736396A (en) * | 1995-01-24 | 1998-04-07 | Case Western Reserve University | Lineage-directed induction of human mesenchymal stem cell differentiation |
US7015037B1 (en) * | 1999-08-05 | 2006-03-21 | Regents Of The University Of Minnesota | Multiponent adult stem cells and methods for isolation |
KR100449141B1 (ko) | 2001-04-19 | 2004-09-21 | (주)라이프코드 | 간엽 간세포를 신경세포로 분화시키는 방법 |
CA2507395A1 (en) * | 2002-12-02 | 2004-06-17 | Anges Mg, Inc. | Method for culturing neural stem cells using hepatocyte growth factor |
-
2003
- 2003-10-29 US US10/595,620 patent/US7635591B2/en not_active Expired - Fee Related
- 2003-10-29 AU AU2003273118A patent/AU2003273118B2/en not_active Ceased
- 2003-10-29 JP JP2005509875A patent/JP4126060B2/ja not_active Expired - Fee Related
- 2003-10-29 CA CA002543118A patent/CA2543118C/en not_active Expired - Fee Related
- 2003-10-29 CN CNB2003801106268A patent/CN100554409C/zh not_active Expired - Fee Related
- 2003-10-29 EP EP03754305A patent/EP1687413B8/en not_active Expired - Fee Related
- 2003-10-29 WO PCT/KR2003/002302 patent/WO2005040362A1/en active IP Right Grant
- 2003-10-29 DE DE60319599T patent/DE60319599T8/de active Active
- 2003-10-29 AT AT03754305T patent/ATE388223T1/de active
-
2007
- 2007-01-04 HK HK07100146.6A patent/HK1093755A1/xx not_active IP Right Cessation
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012034296A1 (zh) * | 2010-09-13 | 2012-03-22 | 中山大学中山眼科中心 | 人表皮源性间充质干细胞样多能细胞及其制备方法 |
CN103275070A (zh) * | 2013-05-10 | 2013-09-04 | 郑彪 | 调节单核细胞增殖的四环化合物及其应用 |
CN103919806A (zh) * | 2014-04-09 | 2014-07-16 | 大连医科大学 | 骨髓间充质干细胞作为治疗正己烷致周围性神经病的药物的应用 |
CN112646774A (zh) * | 2014-09-11 | 2021-04-13 | 台湾粒线体应用技术股份有限公司 | 用线粒体特化细胞治疗神经退行性疾病的医药组合物 |
CN112646774B (zh) * | 2014-09-11 | 2024-05-17 | 台湾粒线体应用技术股份有限公司 | 用线粒体特化细胞治疗神经退行性疾病的医药组合物 |
Also Published As
Publication number | Publication date |
---|---|
CA2543118C (en) | 2009-10-06 |
ATE388223T1 (de) | 2008-03-15 |
EP1687413A1 (en) | 2006-08-09 |
CA2543118A1 (en) | 2005-05-06 |
JP4126060B2 (ja) | 2008-07-30 |
US20070054399A1 (en) | 2007-03-08 |
AU2003273118B2 (en) | 2007-05-17 |
AU2003273118A1 (en) | 2005-05-11 |
HK1093755A1 (en) | 2007-03-09 |
EP1687413B8 (en) | 2008-10-01 |
JP2007528196A (ja) | 2007-10-11 |
DE60319599T8 (de) | 2008-10-16 |
WO2005040362A1 (en) | 2005-05-06 |
EP1687413B1 (en) | 2008-03-05 |
CN100554409C (zh) | 2009-10-28 |
DE60319599T2 (de) | 2008-06-26 |
DE60319599D1 (de) | 2008-04-17 |
US7635591B2 (en) | 2009-12-22 |
EP1687413A4 (en) | 2006-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1549856A (zh) | 使间充质干细胞分化为神经细胞的方法 | |
CN1860224A (zh) | 使间充质干细胞分化成神经细胞的方法以及含有该神经细胞的用于神经退行性疾病的药物组合物 | |
CN1860222A (zh) | 用于临床和商业用途的干细胞 | |
CN1170434A (zh) | 体外诱导多巴胺能的细胞 | |
CN106609263B (zh) | 高效诱导多能干细胞向视网膜色素上皮细胞分化的方法 | |
CN1894401A (zh) | 从人胚胎干细胞衍生终末分化的多巴胺能神经元 | |
CN103013909B (zh) | 一种高效分离禽类胚胎干细胞的方法 | |
CN113549596A (zh) | 一种诱导培养基及其使用方法和应用 | |
JP2004511266A (ja) | 間葉間質細胞に対する治療的利用法 | |
CN1872025A (zh) | 一种美容护肤产品、其制备方法 | |
JP5388297B2 (ja) | アディポクラスター | |
EP1619244B1 (en) | Use of stem cells for inducing neural differentiation | |
CN104928248A (zh) | 一种用于制备神经干细胞的试剂盒及制备神经干细胞的方法 | |
Lescaudron et al. | Assessing the potential clinical utility of transplantations of neural and mesenchymal stem cells for treating neurodegenerative diseases | |
CN1778905A (zh) | 一种脂肪间充质干细胞的分离培养方法及其应用 | |
CN1884494A (zh) | 诱导人胚胎干细胞向肝脏细胞分化的方法及其专用培养基 | |
Momeni-Moghaddam et al. | A simple method for isolation, culture, and in vitro maintenance of chicken spermatogonial stem cells | |
CN108531449A (zh) | 定向诱导大鼠胚胎干细胞分化为心肌细胞的培养基及方法 | |
CN1898380A (zh) | 从乳腺分泌物中分离细胞的方法 | |
WO2023165062A1 (zh) | 一种少突胶质细胞的制备方法及应用 | |
CN101029302A (zh) | 用于治疗帕金森病的多巴胺能神经元和具有增殖能力的前体细胞 | |
CN101054572A (zh) | 人脐血干细胞培养及定向分化为多巴胺能神经细胞的方法及得到的多巴胺能神经细胞的应用 | |
KR20080068351A (ko) | 중간엽 줄기세포에서 신경세포로의 분화 유도 방법 | |
Lucena et al. | Plasticity of mesenchymal stem cells from mouse bone marrow in the presence of conditioned medium of the facial nerve and fibroblast growth factor-2 | |
WO2002034889A2 (en) | Therapeutic uses for mesenchymal stromal cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1093755 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1093755 Country of ref document: HK |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20111222 Address after: Seoul, South Kerean Co-patentee after: Jin Xuanshou Patentee after: Pharmicell Co., Ltd. Address before: Gyeonggi Do, South Korea Co-patentee before: Jin Xuanshou Patentee before: FCB Pharmicell Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20091028 Termination date: 20171029 |